Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial

Heart Rhythm

Volumn 12, Issue 9, 2015, Pages 2010-2017

  Lee, Andy Y ^a   Kutyifa, Valentina ^a   Ruwald, Martin H ^a,b   McNitt, Scott ^a   Polonsky, Bronislava ^a   Zareba, Wojciech ^a   Moss, Arthur J ^a   Ruwald, Anne Christine ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CRT D; Digoxin; Heart failure; ICD; MADIT CRT; Mortality; Ventricular fibrillation; Ventricular tachyarrhythmia

Indexed keywords

DIGOXIN; CARDIOTONIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; FEMALE; HEART BEAT; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS INTERVAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; CANADA; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; EUROPE; FOLLOW UP; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TIME FACTOR; TRENDS; UNITED STATES;

CANADA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOTONIC AGENTS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; UNITED STATES;

EID: 84939774688     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.05.016     Document Type: Article

References (27)

1. W.T. Abraham, W.G. Fisher, A.L. Smith, and et al. Cardiac resynchronization i chronic heart failure N Engl J Med 346 2002 1845 1853
2. I.S. Anand, P. Carson, E. Galle, and et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial Circulation 119 2009 969 977
3. M.R. Bristow, L.A. Saxon, J. Boehmer, and et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
4. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, and L. Tavazzi The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
5. C. Linde, W.T. Abraham, M.R. Gold St, M. John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
6. A.J. Moss, W.J. Hall, D.S. Cannom, and et al. Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
7. A.S. Tang, G.A. Wells, M. Talajic, and et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
8. M. Gheorghiade, K.F. Adams, and W.S. Colucci Digoxin in the management of cardiovascular disorders Circulation 109 2004 2959 2964
9. A. Ahmed, G. Gambassi, M.T. Weaver, J.B. Young, W.H. Wehrmacher, and M.W. Rich Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure Am J Cardiol 100 2007 280 284
10. S.B. Arnold, R.C. Byrd, W. Meister, K. Melmon, M.D. Cheitlin, J.D. Bristow, W.W. Parmley, and K. Chatterjee Long-term digitalis therapy improves left ventricular function in heart failure N Engl J Med 303 1980 1443 1448
11. D. David, E.D. Segni, H.O. Klein, and E. Kaplinsky Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent Am J Cardiol 44 1979 1378 1382
12. J.V. Freeman, J. Yang, S.H. Sung, M.A. Hlatky, and A.S. Go Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure Circ Cardiovasc Qual Outcomes 6 2013 525 533
13. V.V. Georgiopoulou, A.P. Kalogeropoulos, G. Giamouzis, S.A. Agha, M.A. Rashad, S. Waheed, S. Laskar, A.L. Smith, and J. Butler Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy Circ Heart Fail 2 2009 90 97
14. A. Ahmed, R.C. Bourge, G.C. Fonarow, and et al. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure Am J Med 127 2014 61 70
15. A. Ahmed, M.W. Rich, T.E. Love, D.M. Lloyd-Jones, I.B. Aban, W.S. Colucci, K.F. Adams, and M. Gheorghiade Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur Heart J 27 2006 178 186
16. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
17. M. Packer, M. Gheorghiade, J.B. Young, P.J. Costantini, K.F. Adams, R.J. Cody, L.K. Smith, L. Van Voorhees, L.A. Gourley, and M.K. Jolly Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE study N Engl J Med 329 1993 1 7
18. B.F. Uretsky, J.B. Young, F.E. Shahidi, L.G. Yellen, M.C. Harrison, M.K. Jolly PROVED Investigative Group Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial J Am Coll Cardiol 22 1993 955 962
19. E. Adelstein, D. Schwartzman, S. Jain, R. Bazaz, and S. Saba Effect of digoxin on shocks in cardiac resynchronization therapy-defibrillator patients with coronary artery disease Am J Cardiol 113 2014 970 975
20. A.J. Moss, M.W. Brown, D.S. Cannom, and et al. Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 2005 34 43
21. Lee AY, Moss AJ, Ruwald MH, Kutyifa V, McNitt S, Polonsky B, Zareba W, Ruwald AC. Temporal influence of heart failure hospitalizations prior to implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator on subsequent outcome in mild heart failure patients (from MADIT-CRT). Am J Cardiol 2015.
22. D.R. Cox Regression and life-tables J Royal Stat Soc 34 1972 187 220
23. J.P. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Statistical Assoc 94 1999 496 509
24. M.H. Ruwald, A. Abu-Zeitone, C. Jons, A.C. Ruwald, S. McNitt, V. Kutyifa, W. Zareba, and A.J. Moss Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy) J Am Coll Cardiol 62 2013 1343 1350
25. M.R. Rosen, H. Gelband, C. Merker, and B.F. Hoffman Mechanisms of digitalis toxicity: effects of ouabain on phase four of canine Purkinje fiber transmembrane potentials Circulation 47 1973 681 689
26. V. Velebit, P. Podrid, B. Lown, B.H. Cohen, and T.B. Graboys Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs Circulation 65 1982 886 894
27. M.P. Turakhia, P. Santangeli, W.C. Winkelmayer, and et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study J Am Coll Cardiol 64 2014 660 668